台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-康和-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

康和-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/281103.0000.00100.5011,7520.06%
2025/03/257104.9300.00104.5071,7190.41%
2025/03/210106.5029106.91106.50-291,714-1.69%
2025/03/195104.5000.00104.5051,7180.29%
2025/03/1800.005106.50106.50-51,713-0.29%
2025/03/135105.9900.00103.5051,7070.29%
2025/03/1100.001105.50107.00-11,697-0.06%
2025/03/106105.506106.50107.0001,6860.00%
2025/03/0711107.9500.00107.50111,6650.66%
2025/03/0620111.851113.50111.00191,6471.15%
2025/03/041112.5033113.73114.50-321,634-1.96%
2025/03/0327112.7427114.00112.5001,6200.00%
2025/02/278110.6300.00109.0081,5680.51%
2025/02/2641117.163119.00115.50381,5532.45%
2025/02/253112.501114.00113.0021,4430.14%
2025/02/211112.505113.50113.00-41,412-0.28%
2025/02/117111.5015110.40109.00-81,392-0.57%
2025/02/076119.421119.50120.5051,3510.37%
2025/02/064119.2516119.72119.00-121,329-0.90%
2025/02/056110.502110.50113.0041,1940.33%
2025/02/0400.001101.00103.00-11,201-0.08%
2025/01/10194.80196.0097.0001,3550.00%
2025/01/09199.9000.0094.6011,3410.07%
2025/01/064100.005100.30101.50-11,259-0.08%
2025/01/03197.20297.6598.30-11,240-0.08%
2025/01/0200.00395.2093.60-31,235-0.24%
2024/12/06194.40293.7093.30-11,180-0.08%
2024/12/05194.8000.0094.6011,1700.09%
2024/12/04194.6000.0094.6011,1640.09%
2024/12/02195.2000.0094.4011,1580.09%
2024/11/29197.70198.0097.5001,1360.00%
2024/11/19296.2500.0096.0021,0150.20%
2024/11/18299.6500.0096.5021,0100.20%
2024/11/142104.752103.00101.5009710.00%
2024/11/131105.503106.83106.50-2946-0.21%
2024/11/121104.0000.00104.0019160.11%
2024/11/111104.004103.88103.50-3882-0.34%
2024/11/0700.002105.50103.50-2852-0.23%
2024/11/063102.5000.00102.5038260.36%
2024/11/0500.003107.33106.00-3782-0.38%
2024/11/042101.0000.00100.0027580.26%
2024/11/018106.256106.50105.0027300.27%
2024/10/291100.501101.50100.5006040.00%
2024/10/2400.00499.5598.30-4494-0.81%
2024/10/23290.70392.8393.70-1424-0.24%
2024/10/2200.00186.8086.70-1404-0.25%
2024/10/18187.4000.0086.8014500.22%
2024/10/11189.9000.0088.3015020.20%
2024/10/08192.50192.9091.1005070.00%
2024/09/2000.00288.1587.40-2644-0.31%
2024/09/11183.8000.0082.1016560.15%
2024/09/0200.00386.4086.60-3719-0.42%
2024/08/28187.00186.7086.6007290.00%
2024/08/27386.5000.0086.5037340.41%
2024/08/21186.60187.2086.6007460.00%
2024/08/12184.50184.9084.9007800.00%
2024/08/0900.001386.2185.40-13783-1.66%
2024/08/05183.1000.0083.0017640.13%
2024/08/02293.0000.0092.2027410.27%
2024/07/3100.00593.6093.20-5736-0.68%
2024/07/26195.90497.2397.60-3729-0.41%
2024/07/22194.4000.0092.0017180.14%
2024/07/191696.93495.8394.20127081.69%
2024/07/18898.76299.6599.4066760.89%
2024/07/1500.00397.8398.40-3663-0.45%
2024/07/12295.7500.0095.6026480.31%
2024/07/1100.00195.9095.20-1650-0.15%
2024/07/10296.6000.0096.6026580.30%
2024/07/091100.5000.0096.3016680.15%
2024/07/08199.002100.50100.50-1655-0.15%
2024/07/0500.00197.0097.50-1625-0.16%
2024/07/02199.4000.0097.8016230.16%
2024/07/011101.00199.50101.0006100.00%
2024/06/2800.00197.4097.50-1581-0.17%
2024/06/27197.9000.0095.7015820.17%
2024/06/26197.80196.9097.6005760.00%
2024/06/2100.00194.5093.70-1607-0.16%
2024/06/1300.00195.8096.90-1651-0.15%
2024/06/1200.00194.1094.80-1638-0.16%
2024/06/0700.00194.6094.50-1644-0.16%
2024/06/0300.00190.8090.70-1693-0.14%
2024/05/2800.00992.2792.30-9760-1.18%
2024/05/27191.4000.0091.7017760.13%
2024/05/2400.00193.6092.80-1808-0.12%
2024/05/23194.3000.0093.6018420.12%
2024/05/2200.00494.5594.10-4847-0.47%
2024/05/21195.6000.0095.1018500.12%
2024/05/17397.47198.3097.9028720.23%
2024/05/15194.60195.5093.9009520.00%
2024/05/14195.70197.2094.3001,0430.00%
2024/05/1000.00393.0393.30-31,052-0.29%
2024/05/0700.00193.0092.80-11,116-0.09%
2024/04/09297.7500.0097.6021,7220.12%
2024/04/02199.6000.0098.9011,7800.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章